Status:
Enrolling
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With RO7790121 in Participants With Moderately to Severely Active Crohn's Disease
Phase
III
Age
16-80
Sponsor
Hoffmann-La Roche
Enrollment code
600
Last Updated
May 22, 2025
Locations
82 Countries